Group ACYW135 meningococcal polysaccharide conjugate vaccine (Yuxi Walvax Biotech)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameGroup ACYW135 meningococcal polysaccharide conjugate vaccine (Yuxi Walvax Biotech)
Drug Alias NameN/A
ClassificationVaccines > Application > Prophylactic vaccineVaccines > National Immunization Program > Non-immunization program vaccine(Class II)Vaccines > Development/production technology > Conjugated vaccine +[4] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsEncephalomyelitisMeningococcal InfectionsMeningitis, Meningococcal
Global Approved IndicationsMeningitis, Meningococcal
Approved Indications in ChinaMeningitis, Meningococcal
Original Approved Country/TerritoryMainland China
Original Approved Date2012/03/23
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesWalvax Biotechnology Co LtdInternational Centre For Diarrhoeal Disease Research
China Registration ClassN/A

Develop Information

Active CompaniesWalvax Biotechnology Co LtdYuxi Walvax Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsEncephalomyelitisMeningitis, Meningococcal
Inactive IndicationsMeningococcal Infections

Other Information

ATC CodeJ07AH08
Related LinksN/A